Center for Translationel Forskning

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Denmark 86%
3. Cohort Studies 77%
4. Observational Studies 66%
5. Coronavirus 58%
6. Vital Signs 55%
7. Randomized Controlled Trials 54%
8. Placebos 54%
9. Glucagon-Like Peptide-1 Receptor 47%
10. Mortality 46%
11. Severe Acute Respiratory Syndrome 43%
12. Glucose 43%
13. Hospital Emergency Service 41%
14. Prospective Studies 40%
15. Chronic Obstructive Pulmonary Disease 36%
16. Cross-Over Studies 35%
17. Hyperoxia 34%
18. Oxygen 32%
19. SARS Virus 30%
20. alpha-Synuclein 30%
21. Multiple System Atrophy 28%
22. Hypoglycemia 28%
23. Obesity 27%
24. Synucleins 24%
25. Ketones 24%
26. Quality of Life 24%
27. Synucleinopathies 24%
28. Cognition 24%
29. Pandemics 23%
30. Sensory Gating 23%
31. Mannose-Binding Lectin 23%
32. Hospitalization 22%
33. Hypoglycemic Agents 22%
34. Peptides 22%
35. Polypharmacy 22%
36. Parkinson Disease 22%
37. Early Warning Score 21%
38. Psoriatic Arthritis 20%
39. Sodium-Glucose Transport Proteins 20%
40. Occupational Groups 20%
41. Ketone Bodies 19%
42. Confidence Intervals 19%
43. Clinical Studies 19%
44. Glucagon 18%
45. Infections 18%
46. Antioxidants 18%
47. Delivery of Health Care 18%
48. Therapeutics 18%
49. Cognitive Dysfunction 17%
50. Brain 17%
51. gastric inhibitory polypeptide receptor 17%
52. Muscle Strength 17%
53. Dyspnea 16%
54. Vaccination 16%
55. Heart Failure 16%
56. Insulin 15%
57. Coronavirus Infections 15%
58. coronavirus receptor 15%
59. Glucagon-Like Peptide 1 15%
60. Acetylcysteine 15%
61. Type 1 Diabetes Mellitus 15%
62. Antibodies 15%
63. Pragmatic Clinical Trials 14%
64. Systemic Inflammatory Response Syndrome 14%
65. Health Personnel 14%
66. Prefrontal Cortex 14%
67. exendin (9-39) 14%
68. Systematic Reviews 13%
69. Prepulse Inhibition 13%
70. Respiratory Rate 13%
71. RNA 13%
72. Transcutaneous Blood Gas Monitoring 13%
73. Neurodegenerative Diseases 13%
74. Sepsis 13%
75. Passive Immunization 13%
76. Case-Control Studies 13%
77. Hydroxybutyrates 13%
78. Phenotype 13%
79. Asthma 13%
80. metabotropic glutamate receptor 2 12%
81. Wounds and Injuries 12%
82. Perfusion Index 12%
83. Comorbidity 12%
84. Eating 12%
85. Geriatrics 12%
86. Liraglutide 11%
87. Seroepidemiologic Studies 11%
88. BCG Vaccine 11%
89. Hyperglycemia 11%
90. Short Bowel Syndrome 11%
91. Glucokinase 11%
92. Glycocalyx 11%
93. Equivalence Trials 11%
94. Appetite Regulation 11%
95. Gene Expression 11%
96. Hepcidins 11%
97. Rural Hospitals 11%
98. Dipeptidyl-Peptidase IV Inhibitors 10%
99. Parvalbumins 10%
100. semaglutide 10%